1985
DOI: 10.1007/978-3-642-69524-7_11
|View full text |Cite
|
Sign up to set email alerts
|

Molsidomine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1987
1987
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…Sydnonimines were initially used as antihypertensive agents. , Molsidomine has been used in several European countries as an antianginal drug One of the main advantages of molsidomine is the absence of tolerance. Whereas molsidomine itself is only poorly vasoactive in vitro, its metabolite SIN-1 is a potent vasorelaxant and antiplatelet agent.…”
Section: Biological Applicationsmentioning
confidence: 99%
“…Sydnonimines were initially used as antihypertensive agents. , Molsidomine has been used in several European countries as an antianginal drug One of the main advantages of molsidomine is the absence of tolerance. Whereas molsidomine itself is only poorly vasoactive in vitro, its metabolite SIN-1 is a potent vasorelaxant and antiplatelet agent.…”
Section: Biological Applicationsmentioning
confidence: 99%
“…In continuation of our interest in sydnone derived carbenes 45 we report here on N-heterocyclic carbenes of two sydnone imines, among those the carbene of Molsidomine. This orally active vasodilating drug for the prevention of angina pectoris attacks 47 is the subject of intense ongoing pharmacological research, [48][49][50][51][52] however, during the last decade not much effort has been directed toward its chemical properties. We present some surprising results in the light of the relationship between mesomeric betaines and Nheterocyclic carbenes.…”
Section: A R T I C L E I N F O Abstractmentioning
confidence: 99%
“…SIN -1 acts as a potent hypotensive and spasmolytic agent that is without influence on the autonomic nervous system. It only interacts directly with vascular smooth muscles and has a negative inotropic effect, reducing cardiac preload and afterload, as well as peripheral blood pressure [46].…”
Section: Direct Donorsmentioning
confidence: 99%
“…These findings have guided research efforts towards NO therapy as treatment for post-menopausal osteoporosis [46]. The clinical trials that have been performed so far, however, have returned varied results.…”
Section: No In Osteoporosismentioning
confidence: 99%